Meningococcal meningitis, unspecified
ICD-10 A39.1 is a billable code used to indicate a diagnosis of meningococcal meningitis, unspecified.
Meningococcal meningitis is a serious bacterial infection of the protective membranes covering the brain and spinal cord, caused by Neisseria meningitidis. This condition can lead to severe complications, including neurological damage, septicemia, and death if not treated promptly. Symptoms typically include sudden onset of fever, headache, stiff neck, nausea, vomiting, increased sensitivity to light, and altered mental status. The unspecified designation indicates that the specific serogroup of Neisseria meningitidis is not identified, which can complicate treatment and epidemiological tracking. Diagnosis is primarily through clinical evaluation and confirmation via lumbar puncture and cerebrospinal fluid analysis. Treatment usually involves intravenous antibiotics, such as ceftriaxone or penicillin, and may require adjunctive therapies like corticosteroids to reduce inflammation. Vaccination is a key preventive measure, particularly in high-risk populations.
Detailed clinical notes on symptoms, lab results, and treatment plans.
Diagnosis and management of meningitis outbreaks, treatment of individual cases.
Need for clear documentation of serogroup if known, and rationale for treatment choices.
Comprehensive neurological assessments and follow-up notes.
Evaluation of neurological deficits post-meningitis treatment.
Documentation of neurological status changes and any sequelae.
Used to obtain CSF for analysis in suspected meningitis cases.
Document indication for procedure, findings, and any complications.
Neurology and Infectious Disease specialists should ensure thorough documentation of clinical rationale.
A39.1 is used when the specific serogroup of Neisseria meningitidis is not identified, while A39.0 is used when the infection is specifically due to serogroup A.
